CHO Edge System logo

CHO Edge System

Data-driven CHO cell line development achieving 8-12 g/L titers across antibody and bispecific modalities.

Solution by Asimov
Visit website

Overview

The CHO Edge Expression System, developed by Asimov, is a biologics expression platform designed for biologics developers working across discovery, cell line development (CLD), and GMP manufacturing. It combines a high-performance CHO host, vector design tools, and computational modeling to routinely achieve titers of 8–12 g/L before process development, across multiple modalities including standard mAbs, fusion proteins, and multi-chain bispecifics.

The system is positioned as an end-to-end solution, covering lead optimization through process and analytical development. It is available either as a licensed system or through Asimov's CLD service.

Rapid Pools

  • Addresses the limitation of transient expression systems, which often fail to predict how a molecule will perform in stable cell line manufacturing at scale.
  • Uses the same CHO host, vectors, and media from the stable CLD process to generate characterized pools in two weeks.
  • Provides manufacturability data early in development, enabling identification of problematic candidates before they advance further in the pipeline.

Cell Line Development

  • Routinely produces clones at 8–12 g/L before process development across modalities: standard mAbs, fusion proteins, 2-chain, 3-chain, and 4-chain bispecifics.
  • Uses Asimov's Kernel design software to optimize vector variants for the specific architecture of each molecule.
  • Delivers a high-titer Research Cell Bank in 14 weeks, with a guaranteed timeline.

Process Development

  • Pairs the CHO Edge host with hybrid physics-informed machine learning models to co-optimize the clone and process together.
  • Designed to support consistent performance from screening through 2,000L GMP production.
  • Aims to ensure that high-performing clones translate reliably to manufacturing scale.

Asimov is based in Boston, MA, and offers access to the CHO Edge System through licensing or as a CLD service. The platform integrates genetic tools with data-driven models, with Kernel serving as the underlying computational design software for vector optimization.

Meta

Domain
Manufacturing & Bioprocessing
Subdomain
AI-Driven Manufacturing Intelligence
Software type(s)
Computational Engine
Deployment type(s)
Cloud / SaaS
Industry vertical(s)
PharmaBiotechCRO
Development stage(s)
ManufacturingPreclinical / Pre-MarketResearch & Discovery
Target user(s)
Bench Scientist / Lab TechnicianResearch ScientistBioinformatician / Computational Scientist
Compliance standard(s)
GxP
Tag(s)
Uses AI